All Stories

  1. Silk Fibroin Hydrogels: Cutting-edge Developments and Future Directions

    Article • Pharmaceutical Nanotechnology, August 2026, Bentham Science Publishers

    Viswas Raja Solomon, Mr Sabarees Govindaraj, veerasamy Alagarsamy, Dr. JAYARAMAN RAJANGAM

  2. A Comprehensive Overview of the Chemistry and Biological Activities of Flavonoids

    Article • Current Drug Therapy, April 2026, Bentham Science Publishers

    Dr.Gnana Ruba Priya, Viswas Raja Solomon

  3. Innovative Approaches to Alzheimer's Treatment: Utilizing Tacrine Hybrids to Inhibit Amyloid Beta Aggregation as a Strategic Focus

    Article • Mini-Reviews in Medicinal Chemistry, March 2026, Bentham Science Publishers

    Prabakaran A, Viswas Raja Solomon

  4. Computer-aided Drug Discovery Approaches in the Identification of Anticancer Drugs from Natural Products: A Review

    Article • Current Computer - Aided Drug Design, February 2025, Bentham Science Publishers

    Dr.Gnana Ruba Priya, Viswas Raja Solomon, Manisha J A Mascarenhas

  5. Molecular docking and molecular dynamics simulations discover curcumin analogs as potential wound healing agents

    Article • Chemical Physics Impact, June 2024, Elsevier

    Viswas Raja Solomon

  6. Computational Screening of Some Phytochemicals to Identify Best Modulators for Ligand Binding Domain of Estrogen Receptor Alpha

    Article • Current Pharmaceutical Design, June 2024, Bentham Science Publishers

    veerasamy Alagarsamy, Mr Sabarees Govindaraj, Sulthana M T, Viswas Raja Solomon, Dr Shyam Sundar Pottabathula

  7. Fabrication of Quercetin-Functionalized Morpholine and Pyridine Motifs-Laden Silk Fibroin Nanofibers for Effective Wound Healing in Preclinical Study

    Article • Pharmaceutics, March 2024, MDPI AG

    Viswas Raja Solomon

  8. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 Mpro Target

    Article • Medicinal Chemistry, November 2023, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, veerasamy Alagarsamy, Jubie Jawahar, Viswas Raja Solomon, Sulthana M T, Kotha Rohitha

  9. Recent Trends in Electrospun Antibacterial Nanofibers for Chronic Wound Management

    Article • Current Nanomedicine, November 2023, Bentham Science Publishers

    Viswas Raja Solomon, Mr Sabarees Govindaraj, veerasamy Alagarsamy

  10. Screening Active Phytochemicals of Some Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 M pro by Computational Investigation

    Article • Letters in Drug Design & Discovery, September 2023, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, veerasamy Alagarsamy, Sulthana M T, Viswas Raja Solomon

  11. Electrospun Scaffold-based Antibiotic Therapeutics for Chronic Wound Recovery

    Article • Mini-Reviews in Medicinal Chemistry, September 2023, Bentham Science Publishers

    Mr Sabarees Govindaraj, Viswas Raja Solomon, veerasamy Alagarsamy

  12. Biodistribution of nanodiamonds is determined by surface functionalization

    Article • Diamond and Related Materials, August 2023, Elsevier

    Viswas Raja Solomon

  13. Recent Developments in Electrospun Nanofibers as Delivery of Phytoconstituents for Wound Healing

    Article • Drugs and Drug Candidates, March 2023, MDPI AG

    Mr Sabarees Govindaraj, Viswas Raja Solomon

  14. Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics

    Article • Journal of Biomolecular Structure and Dynamics, March 2023, Taylor & Francis

    Dr Shyam Sundar Pottabathula, Viswas Raja Solomon

  15. Isolation, Functionalization, In Silico Investigation, and Synthesis of 1,8-Cineole Analog as Antitubercular Agent Targeting InhA

    Article • Russian Journal of Bioorganic Chemistry, February 2023, Pleiades Publishing Ltd

    Mr Sabarees Govindaraj, Viswas Raja Solomon

  16. Drug Repurposing: An Effective Tool in Modern Drug Discovery

    Article • Russian Journal of Bioorganic Chemistry, February 2023, Pleiades Publishing Ltd

    Viswas Raja Solomon, Dr Murugesan Sankarganesh

  17. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets

    Article • Current Computer - Aided Drug Design, February 2023, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, Viswas Raja Solomon

  18. Advances in electrospun chitosan nanofiber biomaterials for biomedical applications

    Article • Materials Advances, January 2023, Royal Society of Chemistry

    Viswas Raja Solomon

  19. Emerging Trends in Curcumin Embedded Electrospun Nanofibers for Impaired Diabetic Wound Healing

    Article • Applied Nano, November 2022, MDPI AG

    Mr Sabarees Govindaraj, Viswas Raja Solomon

  20. Design, Synthesis, and Structure–Activity Relationships of Novel N-Substituted-5-phenyl-[1,2,4]triazolo[1,5-c]quinazolin-2-amine for Their Anti-HIV and Antibacterial Activities

    Article • Russian Journal of Bioorganic Chemistry, October 2022, Pleiades Publishing Ltd

    Viswas Raja Solomon

  21. Recent Advances in Silver Nanoparticles Containing Nanofibers for Chronic Wound Management

    Article • Polymers, September 2022, MDPI AG

    Mr Sabarees Govindaraj, Viswas Raja Solomon

  22. Design, Synthesis, and Structure–Activity Relationships of Novel 1-(Substituted)-2-Methyl-3-(4-Oxo-2-Methylquinazolin-3(4H)-yl) Isothioureas for Their Anti-HIV and Antibacterial Activities

    Article • Russian Journal of Bioorganic Chemistry, June 2022, Pleiades Publishing Ltd

    Viswas Raja Solomon

  23. Radionanotheranostics for breast cancer diagnosis and therapy: recent advances and future opportunities

    Article • January 2022, Elsevier

    Viswas Raja Solomon

  24. Concussion/Mild Traumatic Brain Injury (TBI) Induces Brain Insulin Resistance: A Positron Emission Tomography (PET) Scanning Study

    Article • International Journal of Molecular Sciences, August 2021, MDPI AG

    Viswas Raja Solomon

  25. Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety

    Article • BMC Cancer, March 2021, Springer Science + Business Media

    Viswas Raja Solomon

  26. 89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo

    Article • Cancers, February 2021, MDPI AG

    Viswas Raja Solomon

  27. Anti-HIV and Antibacterial Activities of Novel 2-(3-Substituted-4-oxo-3,4-dihydroquinazolin-2-yl)-2,3-dihydrophthalazine-1,4-diones

    Article • Russian Journal of Bioorganic Chemistry, January 2021, Pleiades Publishing Ltd

    Viswas Raja Solomon

  28. Nimotuzumab Site-Specifically Labeled with 89Zr and 225Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers

    Article • Cancers, November 2020, MDPI AG

    Viswas Raja Solomon

  29. Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Viswas Raja Solomon

  30. Ultrasonic-Assisted Solid-Phase Peptide Synthesis of DOTA-TATE and DOTA-linker-TATE Derivatives as a Simple and Low-Cost Method for the Facile Synthesis of Chelator–Peptide Conjugates

    Article • Bioconjugate Chemistry, July 2020, American Chemical Society (ACS)

    Viswas Raja Solomon

  31. Design and Synthesis of 1-Substituted-4-(4-Nitrophenyl)-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-ones as a New Class of Antihistaminic Agents

    Article • Russian Journal of Bioorganic Chemistry, May 2020, Pleiades Publishing Ltd

    Viswas Raja Solomon

  32. 111In- and 225Ac-Labeled Cixutumumab for Imaging and α-Particle Radiotherapy of IGF-1R Positive Triple-Negative Breast Cancer

    Article • Molecular Pharmaceutics, September 2019, American Chemical Society (ACS)

    Viswas Raja Solomon

  33. GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators

    Article • European Journal of Medicinal Chemistry, June 2019, Elsevier

    Viswas Raja Solomon

  34. Examination of novel 4-aminoquinoline derivatives designed and synthesized by a hybrid pharmacophore approach to enhance their anticancer activities

    Article • Scientific Reports, April 2019, Springer Science + Business Media

    Viswas Raja Solomon

  35. Preclinical Evaluation of 111In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models

    Article • Journal of Nuclear Medicine, January 2019, Society of Nuclear Medicine

    Viswas Raja Solomon

  36. Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2019, Taylor & Francis

    Viswas Raja Solomon

  37. A 89Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior

    Article • International Journal of Nanomedicine, November 2018, Dove Medical Press

    AMAL Makhlouf, humphrey fonge, Deborah L Michel, Viswas Raja Solomon

  38. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system

    Article • BMC Biotechnology, September 2018, Springer Science + Business Media

    Viswas Raja Solomon

  39. 99mTc(CO)3+ labeled domain I/II-specific anti-EGFR (scFv)2 antibody fragment for imaging EGFR expression

    Article • European Journal of Medicinal Chemistry, September 2018, Elsevier

    Viswas Raja Solomon

  40. An overview of quinazolines: Pharmacological significance and recent developments

    Article • European Journal of Medicinal Chemistry, May 2018, Elsevier

    Viswas Raja Solomon

  41. 89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I

    Article • Oncotarget, March 2018, Impact Journals, LLC

    Viswas Raja Solomon

  42. Exploring the Binding of Barbital to a Synthetic Macrocyclic Receptor. A Charge Density Study

    Article • The Journal of Physical Chemistry A, February 2018, American Chemical Society (ACS)

    Viswas Raja Solomon

  43. Design and synthesis of novel quinacrine-[1,3]-thiazinan-4-one hybrids for their anti-breast cancer activity

    Article • European Journal of Medicinal Chemistry, January 2018, Elsevier

    Viswas Raja Solomon

  44. Design, synthesis and characterization of novel quinacrine analogs that preferentially kill cancer over non-cancer cells through the down-regulation of Bcl-2 and up-regulation of Bax and Bad

    Article • European Journal of Medicinal Chemistry, September 2017, Elsevier

    Viswas Raja Solomon

  45. Design and Synthesis of 3-Substituted-thiazolyl-2-iminothiazolidin-4-ones as a New Class of Anticonvulsants

    Article • Journal of Heterocyclic Chemistry, June 2016, Wiley

    veerasamy Alagarsamy, Viswas Raja Solomon

  46. DESIGN, SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF 1-(4-OXO-3-(4-FLUOROPHENYL)-3H-QUINAZOLIN- 2-YL)-4-(SUBSTITUTED) THIOSEMICARBAZIDE DERIVATIVES

    Article • Journal of the Chilean Chemical Society, June 2016, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    Viswas Raja Solomon

  47. Investigating the Role of Loop C Hydrophilic Residue ‘T244’ in the Binding Site of ρ1 GABAC Receptors via Site Mutation and Partial Agonism

    Article • PLOS One, May 2016, PLOS

    Viswas Raja Solomon

  48. Antimicrobial activities of some synthesized 1-(3-(2-methylphenyl)-4-Oxo-3H-quinazolin-2-yl-4-(substituted)thiosemicarbazide derivatives

    Article • Russian Journal of Bioorganic Chemistry, May 2016, Pleiades Publishing Ltd

    Viswas Raja Solomon

  49. Identification of SNAIL1 Peptide-Based Irreversible Lysine-Specific Demethylase 1-Selective Inactivators

    Article • Journal of Medicinal Chemistry, January 2016, American Chemical Society (ACS)

    Viswas Raja Solomon

  50. The Direct Actions of GABA, 2’-Methoxy-6-Methylflavone and General Anaesthetics at β3γ2L GABAA Receptors: Evidence for Receptors with Different Subunit Stoichiometries

    Article • PLOS One, October 2015, PLOS

    Viswas Raja Solomon

  51. VR23: A Quinoline–Sulfonyl Hybrid Proteasome Inhibitor That Selectively Kills Cancer via Cyclin E–Mediated Centrosome Amplification

    Article • Cancer Research, September 2015, American Association for Cancer Research (AACR)

    Viswas Raja Solomon

  52. Synthesis of 1-Substituted-4-(Pyridin-4-yl) [1,2,4] Triazolo [4,3-a] Quinazolin-5(4H)-ones as a New Class of H1- Antihistaminic Agents

    Article • Tropical Journal of Pharmaceutical Research, March 2015, African Journals Online (AJOL)

    Viswas Raja Solomon

  53. Design and synthesis of quinazolinyl acetamides for their analgesic and anti-inflammatory activities

    Article • Zeitschrift für Naturforschung B, January 2015, De Gruyter

    veerasamy Alagarsamy, Viswas Raja Solomon

  54. Synthesis and antimicrobial activities of 1-(3-benzyl-4-oxo-3H-quinazolin-2-yl)-4-(substituted)thiosemicarbazide derivatives

    Article • Journal of the Serbian Chemical Society, January 2015, National Library of Serbia

    Viswas Raja Solomon

  55. The potential of quinoline derivatives for the treatment of Toxoplasma gondii infection

    Article • Experimental Parasitology, October 2014, Elsevier

    Viswas Raja Solomon

  56. Design and synthesis of 3-(4-chlorophenyl)-2-(2-(4-substituted)-2-oxoethylthio)quinazolin-4(3H)-one as antihistamine agents

    Article • Medicinal Chemistry Research, May 2014, Springer Science + Business Media

    Viswas Raja Solomon

  57. Design, synthesis and biological evaluation of some isatin-linked chalcones as novel anti-breast cancer agents: A molecular hybridization approach

    Article • Biomedicine & Preventive Nutrition, October 2013, Elsevier

    Chandrabose Karthikeyan, Viswas Raja Solomon

  58. Synthesis and biological evaluation of 2-(phenyl)-3H-benzo[d]imidazole-5-carboxylic acids and its methyl esters as potent anti-breast cancer agents

    Article • Arabian Journal of Chemistry, July 2013, Elsevier

    Chandrabose Karthikeyan, Viswas Raja Solomon

  59. Synthesis of novel 2-phenyl-3-[2-(substituted amino) ethylamino] quinazolin-4(3H)-ones as a new class of H1-antihistaminic agents

    Article • Medicinal Chemistry Research, September 2012, Springer Science + Business Media

    Dr Shyam Sundar Pottabathula, Viswas Raja Solomon

  60. Design and synthesis of 3-[(7-chloro-1-oxidoquinolin-4-ylamino)alkyl]-1,3-thiazolidin-4-ones as antimalarial agents

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, September 2012, Taylor & Francis

    Viswas Raja Solomon

  61. Synthesis and Pharmacological Investigation of 5-Substituted-3-methylsulfanyl-1H-pyrazole-4-carboxylic Acid Ethyl Esters as New Analgesic and Anti-inflammatory Agents

    Article • Arzneimittelforschung, August 2012, Thieme Publishing Group

    veerasamy Alagarsamy, Viswas Raja Solomon

  62. 2,3-Disubtituted Thiazolidin-4-ones: Novel Class of Anticonvulsant Agents

    Article • Letters in Drug Design & Discovery, June 2012, Bentham Science Publishers

    Viswas Raja Solomon

  63. Anti-breast cancer activity of heteroaryl chalcone derivatives

    Article • Biomedicine & Pharmacotherapy, April 2012, Elsevier

    Viswas Raja Solomon

  64. Synthesis and Antibacterial Activity of Some Novel 1-(4-Oxo-3-(3- methoxyphenyl)-3H-quinazolin-2-yl)-4-(substituted) thiosemicarbazides

    Article • Anti-Infective Agents, March 2012, Bentham Science Publishers

    Viswas Raja Solomon

  65. Design, synthesis of 4-aminoquinoline-derived thiazolidines and their antimalarial activity and heme polymerization inhibition studies

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, March 2012, Taylor & Francis

    Viswas Raja Solomon

  66. Synthesis and Pharmacological Evaluation of Some 3-(2-Methylphenyl)-2-Substituted Amino-quinazolin-4(3H)-ones as Analgesic and Anti-inflammatory Agents

    Article • Arzneimittelforschung, December 2011, Thieme Publishing Group

    Viswas Raja Solomon

  67. Design, synthesis and biological evaluation of some novel 3-cinnamoyl-4-hydroxy-2H-chromen-2-ones as antimalarial agents

    Article • Medicinal Chemistry Research, June 2011, Springer Science + Business Media

    Dr N.S. Hari Narayana moorthy, Chandrabose Karthikeyan, Viswas Raja Solomon

  68. Synthesis of Some Coumarinyl Chalcones and their Antiproliferative Activity Against Breast Cancer Cell Lines

    Article • Letters in Drug Design & Discovery, May 2011, Elsevier

    Dr N.S. Hari Narayana moorthy, Chandrabose Karthikeyan, Viswas Raja Solomon

  69. Quinoline as a Privileged Scaffold in Cancer Drug Discovery

    Article • Current Medicinal Chemistry, April 2011, Bentham Science Publishers

    Viswas Raja Solomon

  70. 4-Aminoquinoline derived antimalarials: Synthesis, antiplasmodial activity and heme polymerization inhibition studies

    Article • European Journal of Medicinal Chemistry, November 2010, Elsevier

    Viswas Raja Solomon

  71. Synthesis and analgesic, anti-inflammatory activities of 3-(3-methoxyphenyl)-2-substituted amino-quinazolin-4(3H)-ones

    Article • Medicinal Chemistry Research, September 2010, Springer Science + Business Media

    Viswas Raja Solomon

  72. Design and synthesis of chloroquine analogs with anti-breast cancer property

    Article • European Journal of Medicinal Chemistry, September 2010, Elsevier

    Viswas Raja Solomon

  73. A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells

    Article • European Journal of Medicinal Chemistry, February 2010, Elsevier

    Viswas Raja Solomon

  74. Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: A hybrid pharmacophore approach

    Article • Bioorganic & Medicinal Chemistry, February 2010, Elsevier

    Viswas Raja Solomon

  75. Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies

    Article • European Journal of Pharmacology, December 2009, Elsevier

    Viswas Raja Solomon

  76. Hybrid pharmacophore design and synthesis of isatin–benzothiazole analogs for their anti-breast cancer activity

    Article • Bioorganic & Medicinal Chemistry, November 2009, Elsevier

    Viswas Raja Solomon

  77. 3-(3-Ethylphenyl)-2-substituted hydrazino-3H-quinazolin-4-one Derivatives: New Class of Analgesic and Anti-Inflammatory Agents

    Article • Chemical Biology & Drug Design, April 2009, Wiley

    Viswas Raja Solomon

  78. Synthesis and pharmacological evaluation of 3-cyclohexyl-2-substituted hydrazino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents

    Article • Acta Pharmaceutica, January 2009, De Gruyter

    Viswas Raja Solomon

  79. Synthesis and pharmacological investigation of novel 4-(3-ethylphenyl)-1-substituted-4H-[1,2,4]triazolo[4,3-a] quinazolin-5-ones as a new class of H1-antihistaminic agents

    Article • Acta Pharmaceutica, January 2009, De Gruyter

    Viswas Raja Solomon

  80. Topological descriptors in modelling antimalarial activity: N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine as prototype

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, October 2008, Taylor & Francis

    Viswas Raja Solomon

  81. The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine

    Article • Bioorganic & Medicinal Chemistry, September 2008, Elsevier

    Viswas Raja Solomon

  82. Synthesis and Antimalarial Activity of Novel Side Chain Modified Antimalarial Agents Derived from 4-Aminoquinoline

    Article • Medicinal Chemistry, September 2008, Bentham Science Publishers

    Viswas Raja Solomon

  83. Synthesis of 3-(2-pyridyl)-2-substituted-quinazolin-4(3H)-ones as new analgesic and anti-inflammatory agents

    Article • Biomedicine & Pharmacotherapy, September 2008, Elsevier

    Dr Durai Ananda Kumar T, Viswas Raja Solomon

  84. Synthesis and pharmacological evaluation of 3‐(4‐chloro phenyl)‐2‐substituted‐3H‐quinazolin‐4‐ones as analgesic and anti‐inflammatory agents

    Article • Drug Development Research, June 2008, Wiley

    Viswas Raja Solomon

  85. Synthesis and pharmacological investigation of novel 4‐(4‐Ethyl phenyl)‐1‐substituted‐4H‐[1,2,4]triazolo[4,3‐a]‐quinazolin‐5‐ones as new class of H1‐antihistaminic agents

    Article • Journal of Heterocyclic Chemistry, May 2008, Wiley

    Viswas Raja Solomon

  86. Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives

    Article • Biomedicine & Pharmacotherapy, February 2008, Elsevier

    Viswas Raja Solomon

  87. Design and synthesis of 3-(4-Ethylphenyl)-2-substituted amino-3H-quinazolin-4-ones as a novel class of analgesic and anti-inflammatory agents

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2008, Taylor & Francis

    Viswas Raja Solomon

  88. Synthesis of Novel 3-Butyl-2-Substituted Amino-3H-Quinazolin-4-ones as Analgesic and Anti-inflammatory Agents

    Article • Chemical Biology & Drug Design, September 2007, Wiley

    Dr Durai Ananda Kumar T, Viswas Raja Solomon

  89. 4-Cyclohexyl-1-substituted-4H-[1,2,4]triazolo [4,3-a] quinazolin-5-ones: Novel Class of H1-antihistaminic Agents

    Article • Chemical Biology & Drug Design, August 2007, Wiley

    Dr Durai Ananda Kumar T, Viswas Raja Solomon

  90. Synthesis and Pharmacological Investigation of 3‐Subsituted‐amino‐2‐methylsulfanyl‐5,6,7,8‐tetrahydro‐3H‐benzo[4,5]thieno[2,3‐d]pyrimidin‐4‐ones as Analgesic and Anti‐Inflammatory Agents

    Article • Archiv der Pharmazie, July 2007, Wiley

    Viswas Raja Solomon

  91. Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents

    Article • Bioorganic & Medicinal Chemistry, June 2007, Elsevier

    Viswas Raja Solomon

  92. Synthesis of 2-mercapto-3-substituted-5,6-dimethylthieno[2,3-d] pyrimidin-4(3H)-ones as new analgesic, anti-inflammatory agents

    Article • Biomedicine & Pharmacotherapy, June 2007, Elsevier

    Viswas Raja Solomon

  93. Synthesis of some novel 2-mercapto-3-(substituted amino)-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d]pyrimidin-4-ones as analgesic and anti-inflammatory agents

    Article • ARKIVOC, February 2007, ARKAT USA, Inc.

    Viswas Raja Solomon

  94. Design and Synthesis of 2-Methylthio-3-substituted-5,6-dimethylthieno [2,3-d] pyrimidin-4(3H)-ones as Analgesic, Anti-Inflammatory and Antibacterial Agents

    Article • Medicinal Chemistry, January 2007, Bentham Science Publishers

    Viswas Raja Solomon

  95. Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents

    Article • Bioorganic & Medicinal Chemistry, January 2007, Elsevier

    Viswas Raja Solomon

  96. Synthesis and Antimalarial Activity of Side Chain Modified 4-Aminoquinoline Derivatives

    Article • Journal of Medicinal Chemistry, December 2006, American Chemical Society (ACS)

    Viswas Raja Solomon

  97. Synthesis, analgesic, anti-inflammatory, ulcerogenic index and antibacterial activities of novel 2-methylthio-3-substituted-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-4(3H)-ones

    Article • European Journal of Medicinal Chemistry, November 2006, Elsevier

    Viswas Raja Solomon

  98. Design, Synthesis and Antimalarial Activity of a New Class of Iron Chelators

    Article • Medicinal Chemistry, March 2006, Bentham Science Publishers

    Viswas Raja Solomon

  99. Topological Descriptors in Modeling the HIV Inhibitory Activity of 2-Aryl-3- pyridyl-thiazolidin-4-ones

    Article • Combinatorial Chemistry & High Throughput Screening, August 2005, Bentham Science Publishers

    Viswas Raja Solomon

  100. Synthesis and QSAR Studies on Thiazolidinones as Anti-HIV Agents

    Article • Combinatorial Chemistry & High Throughput Screening, August 2005, Bentham Science Publishers

    Dr Ravindra K Rawal, Viswas Raja Solomon

  101. Design and synthesis of new antimalarial agents from 4-aminoquinoline

    Article • Bioorganic & Medicinal Chemistry, March 2005, Elsevier

    Viswas Raja Solomon

  102. Synthesis, Analgesic, Anti-inflammatory and Antibacterial Activities of Some Novel 2-Butyl-3-substituted Quinazolin-4-(3H)-ones

    Article • Biological and Pharmaceutical Bulletin, January 2005, Pharmaceutical Society of Japan

    Viswas Raja Solomon

  103. Synthesis, Analgesic, Anti-inflammatory and Antibacterial Activities of Some Novel 2-Phenyl-3-substituted Quinazolin-4(3H) Ones.

    Article • Biological and Pharmaceutical Bulletin, January 2002, Pharmaceutical Society of Japan

    Viswas Raja Solomon